A novel ryanodine receptor in the hormonal regulation of hepatic metabolism
肝脏代谢激素调节中的新型兰尼定受体
基本信息
- 批准号:8058627
- 负责人:
- 金额:$ 19.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-15 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:BiochemicalBrainCaffeineCalcium SignalingCatecholaminesCellsChinese Hamster Ovary CellCholestasisComplexCyclic ADP-RiboseDiseaseDoseEndocrineEpitheliumFeedbackFrequenciesGastrointestinal tract structureGene ExpressionGenerationsGenesHealthHepaticHepatitisHepatocyteHormonalHormonesITPR1 geneInositolInvestigationLengthLiverMediatingMetabolismMolecular StructureMusclePancreasPancreatitisPathway interactionsPatternPhysiologicalPlayProcessPropertyProtein IsoformsProteinsPublic HealthRattusRegulationRoleRyR1RyanodineRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSecond Messenger SystemsSecretory CellSeriesSignal PathwaySignal TransductionSignaling ProteinSiteTissuesVasopressinsWorkcell preparationhormone regulationimprovedinhibitor/antagonistinnovationliver functionnew therapeutic targetnovelpublic health relevancereceptorresponsesecond messenger
项目摘要
DESCRIPTION (provided by applicant): The effects of hormones such as catecholamines and vasopressin on hepatic metabolism and secretion are mediated by alterations in the concentration of cytosolic free Ca2+ ([Ca2+]c), largely as a result of Ca2+ mobilization from intracellular stores by the second messenger inositol 1,4,5-trisphosphate (IP3). The [Ca2+]c signals elicited by these hormones are organized in the form of [Ca2+]c oscillations and waves, whose frequency is controlled by hormone dose. Frequency-modulated [Ca2+]c oscillations may serve a number of regulatory functions, including improved fidelity, sensitivity and targeted regulation of specific processes. While the role of IP3-receptors in this pathway is well established, it has recently become evident that other Ca2+ release and Ca2+-feedback components contribute to extend the temporal and spatial range of [Ca2+]c oscillations. One way in which this might be achieved is through interplay between IP3R and the other major class of intracellular Ca2+ release channels, the ryanodine receptors (RyRs). RyRs are typically activated by Ca2+ through a Ca2+-induced Ca2+ release (CICR) mechanism, but they can also be activated by another second messenger, cyclic-ADPribose (cADPR). Although the RyRs have been well-characterized in excitable tissues (primarily muscle and brain), relatively little is known about the identity and properties of RyRs in nonexcitable cells. We have recently identified and cloned a unique RyR isoform from rat hepatocytes (RyR1b), which is derived from the RyR1 gene, but with an alternative start site that gives rise to a protein of only 40% the size of full length muscle RyRs. We hypothesize that RyR1b has distinct functional properties that underlie its contribution to [Ca2+]c signaling in hepatocytes and other nonexcitable secretory cells, where it may be the principal RyR isoform. Specifically, we propose that RyR1b plays a key role in enhancing and sustaining ER Ca2+ release initiated by IP3R activation. We will examine the potential role of RyR1b in two specific aims: In Aim 1 we will carry out heterologous expression studies to investigate the function and regulatory properties of RyR1b, including regulation by [Ca2+]c, cADPR and its interactions with IP3 and the IP3R. In Aim 2 we will investigate the subcellular distribution and regulation of RyR1b in primary hepatocytes, and determine how it contributes to the temporal and spatial pattern of [Ca2+]c signaling during hormonal stimulation of these cells. RyR1b appears to be a major new addition to the superfamily of intracellular Ca2+ release channels, with distinct properties. It may have specific functions that are tuned to the signaling requirements of nonexcitable secretory epithelia and endocrine cells. Thus, the proposed work is innovative and has the potential for high impact, with significant biomedical health relevance.
PUBLIC HEALTH RELEVANCE: The proposed work will investigate the role and regulation of a newly discovered calcium signaling protein (RyR1b) that appears to play a role in mediating the effects of hormones on liver function. It is also postulated to participate in signaling in other tissues, including the pancreas and cells of the digestive tract. Since derangements of signaling in these tissues are frequently associated with disease states (eg. hepatitis, cholestasis, pancreatitis), characterization of the properties of RyR1b has significant potential public health impact. Its unique molecular structure may yield a novel therapeutic target.
描述(由申请人提供):激素如儿茶酚胺的作用 和加压素对肝代谢和分泌的影响是由胞质游离Ca 2+([Ca 2 +]c)浓度的改变介导的,这主要是由于第二信使1,4,5-三磷酸肌醇(IP 3)从细胞内储存的Ca 2+动员的结果。由这些激素引起的[Ca 2 +]c信号以[Ca 2 +]c振荡和波的形式组织,其频率由激素剂量控制。频率调制的[Ca 2 +]c振荡可以提供许多调节功能,包括改善保真度,灵敏度和特定过程的靶向调节。虽然IP 3-受体在这一途径中的作用是公认的,它最近变得很明显,其他Ca 2+释放和Ca 2+反馈组件有助于扩展[Ca 2 +]c振荡的时间和空间范围。其中一种可能实现的方式是通过IP 3R和细胞内Ca 2+释放通道的另一个主要类别,兰尼碱受体(RyRs)之间的相互作用。RyR通常通过Ca 2+诱导的Ca 2+释放(CICR)机制被Ca 2+激活,但它们也可以被另一种第二信使环腺苷三磷酸(cADPR)激活。虽然RyR在可兴奋组织(主要是肌肉和大脑)中已经得到了很好的表征,但对RyR在非兴奋细胞中的身份和性质知之甚少。我们最近从大鼠肝细胞(RyR 1b)中鉴定并克隆了一种独特的RyR亚型,该亚型来源于RyR 1基因,但具有另一个起始位点,其产生的蛋白质仅为全长肌肉RyR大小的40%。我们假设RyR 1b具有独特的功能特性,这些特性是其对肝细胞和其他非兴奋性分泌细胞中[Ca 2 +]c信号传导的贡献的基础,在这些细胞中,它可能是主要的RyR亚型。具体来说,我们建议RyR 1b在增强和维持由IP 3R激活启动的ER Ca 2+释放中起着关键作用。我们将研究RyR 1b在两个特定目标中的潜在作用:在目标1中,我们将进行异源表达研究以研究RyR 1b的功能和调节特性,包括[Ca 2 +]c,cADPR及其与IP 3和IP 3R的相互作用的调节。在目的2中,我们将研究RyR 1b在原代肝细胞中的亚细胞分布和调节,并确定它如何有助于这些细胞激素刺激期间[Ca 2 +]c信号传导的时空模式。RyR 1b似乎是细胞内钙释放通道超家族的一个主要新成员,具有独特的特性。它可能具有特定的功能,这些功能与不可兴奋的分泌上皮细胞和内分泌细胞的信号需求相协调。因此,拟议的工作是创新的,有可能产生很大的影响,具有重大的生物医学健康意义。
公共卫生相关性:这项工作将研究一种新发现的钙信号蛋白(RyR 1b)的作用和调节,该蛋白似乎在介导激素对肝功能的影响方面发挥作用。它也被假定参与其他组织中的信号传导,包括胰腺和消化道细胞。由于这些组织中信号的紊乱通常与疾病状态(例如,肝炎、胆汁淤积、胰腺炎),RyR 1b特性的表征具有显著的潜在公共卫生影响。其独特的分子结构可能产生新的治疗靶点。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW P THOMAS其他文献
ANDREW P THOMAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW P THOMAS', 18)}}的其他基金
Malaria melatonin receptor signaling as a novel drug target
疟疾褪黑激素受体信号传导作为新的药物靶点
- 批准号:
8459979 - 财政年份:2012
- 资助金额:
$ 19.31万 - 项目类别:
Malaria melatonin receptor signaling as a novel drug target
疟疾褪黑激素受体信号传导作为新的药物靶点
- 批准号:
8632988 - 财政年份:2012
- 资助金额:
$ 19.31万 - 项目类别:
Malaria melatonin receptor signaling as a novel drug target
疟疾褪黑激素受体信号传导作为新的药物靶点
- 批准号:
9033819 - 财政年份:2012
- 资助金额:
$ 19.31万 - 项目类别:
Malaria melatonin receptor signaling as a novel drug target
疟疾褪黑激素受体信号传导作为新的药物靶点
- 批准号:
8283963 - 财政年份:2012
- 资助金额:
$ 19.31万 - 项目类别:
Malaria melatonin receptor signaling as a novel drug target
疟疾褪黑激素受体信号传导作为新的药物靶点
- 批准号:
8715947 - 财政年份:2012
- 资助金额:
$ 19.31万 - 项目类别:
A novel ryanodine receptor in the hormonal regulation of hepatic metabolism
肝脏代谢激素调节中的新型兰尼定受体
- 批准号:
7897401 - 财政年份:2010
- 资助金额:
$ 19.31万 - 项目类别:
Ethanol on Excitation-Contraction in Cardiac Cells
乙醇对心肌细胞兴奋收缩的影响
- 批准号:
7856019 - 财政年份:2009
- 资助金额:
$ 19.31万 - 项目类别:
Ethanol on Excitation-Contraction in Cardiac Cells
乙醇对心肌细胞兴奋收缩的影响
- 批准号:
6889987 - 财政年份:2004
- 资助金额:
$ 19.31万 - 项目类别:
Ethanol on Excitation-Contraction in Cardiac Cells
乙醇对心肌细胞兴奋收缩的影响
- 批准号:
7059993 - 财政年份:2004
- 资助金额:
$ 19.31万 - 项目类别:
Ethanol on Excitation-Contraction in Cardiac Cells
乙醇对心肌细胞兴奋收缩的影响
- 批准号:
7227137 - 财政年份:2004
- 资助金额:
$ 19.31万 - 项目类别:
相似国自然基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
- 批准号:81801389
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
- 批准号:81101046
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Extreme Mechanics of the Human Brain via Integrated In Vivo and Ex Vivo Mechanical Experiments
合作研究:通过体内和离体综合力学实验研究人脑的极限力学
- 批准号:
2331294 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Standard Grant
Restoring Brain Plasticity through Sleep
通过睡眠恢复大脑可塑性
- 批准号:
24K09679 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Learning how we learn: linking inhibitory brain circuits to motor learning
了解我们如何学习:将抑制性大脑回路与运动学习联系起来
- 批准号:
DE240100201 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Discovery Early Career Researcher Award
How does the brain process conflicting information?
大脑如何处理相互矛盾的信息?
- 批准号:
DE240100614 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Discovery Early Career Researcher Award
Mobilizing brain health and dementia guidelines for practical information and a well trained workforce with cultural competencies - the BRAID Hub - Brain health Resources And Integrated Diversity Hub
动员大脑健康和痴呆症指南获取实用信息和训练有素、具有文化能力的劳动力 - BRAID 中心 - 大脑健康资源和综合多样性中心
- 批准号:
498289 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Operating Grants
Immunoregulatory functions of appetite controlling brain circuits
食欲控制脑回路的免疫调节功能
- 批准号:
BB/Y005694/1 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Research Grant
Probing the origin and evolution of low-oxidation state iron and copper nanoparticles in the brain
探究大脑中低氧化态铁和铜纳米粒子的起源和演化
- 批准号:
EP/X031403/1 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Research Grant
Understanding the mechanisms underlying the detrimental effects of NAFLD on the brain
了解 NAFLD 对大脑产生有害影响的机制
- 批准号:
MR/X033287/1 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Fellowship
FastMap-IMPACT: Brain mechanisms of rapid language learning: an Investigation of Memory in Patients and Ageing with Consolidation Theory
FastMap-IMPACT:快速语言学习的大脑机制:用巩固理论研究患者记忆和衰老
- 批准号:
EP/Y016815/1 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Fellowship
A Novel Contour-based Machine Learning Tool for Reliable Brain Tumour Resection (ContourBrain)
一种基于轮廓的新型机器学习工具,用于可靠的脑肿瘤切除(ContourBrain)
- 批准号:
EP/Y021614/1 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Research Grant